Teva Plant in JLM is the Right Facility to become a CDMO, this is a win-win situation for Teva and Contract Manufacturers to save an excellent crew with an excellent site.
Teva is downsizing and shedding some of its manufacturing facilities here in Israel, including two of its manufacturing facilities in Jerusalem. One of these facilities
Jlm-Based Orcam Raised $ 30.4 Million at a Value of $ 1 Billion
February 20, 2018 – $1.01B: Jerusalem -based computer vision startup OrCam Technologies, which has developed a visual aid for the blind, became the latest company to make
Alynnovation is Open for Entrepreneurs in Assistive Technologies for Children
March 7, 2018 ALYN Hospital has opened ALYNnovation, a commercial track that partners with entrepreneurs and inventors in developing and commercializing assistive technology products and solutions for children on a global scale
Granalix’s Pomegranate Extract is an Israeli Supplement for Preventing and Improving Neurodegenerative Diseases
February 26, 2018 – Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause inflammation, accelerated aging of the tissues,
Ran Poliakine’s New Innovation Center is Now Open for Applications
Feb 8, 2018 – Ran Poliakine of Nveh Ilan hase just announced the launch of a brand-new innovation center that intends to focus on early-stage ventures in
Prof. David Naor’s Drug Could Treat Alzheimer’s, MS, Crohn’s and More
February 11,2018 Prof. David Naor, from the Lautenberg Center for General and Tumor Immunology at the Hebrew University-Hadassah Medical School, Jerusalem, believes that all these diseases, which
BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer
Nov. 15, 2017 (GLOBE NEWSWIRE) — BioCancell Therapeutics (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat
Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH With its Oral Insulin Capsule
Nov. 14, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced
World first MRI for the NeoNatal ICU has been successfully working at Jerusalem’s Shaare Zedek Medical Center for the last three months
January 10, 2018 Aspect Imaging ‘s Embrace® dedicated Neonatal Magnetic Resonance Imaging (MRI) system has now received both the EC mark and FDA clearance. The
